James D. Rodgers

4.6k total citations
62 papers, 2.7k citations indexed

About

James D. Rodgers is a scholar working on Infectious Diseases, Organic Chemistry and Virology. According to data from OpenAlex, James D. Rodgers has authored 62 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Infectious Diseases, 19 papers in Organic Chemistry and 13 papers in Virology. Recurrent topics in James D. Rodgers's work include HIV/AIDS drug development and treatment (19 papers), HIV Research and Treatment (13 papers) and Biochemical and Molecular Research (5 papers). James D. Rodgers is often cited by papers focused on HIV/AIDS drug development and treatment (19 papers), HIV Research and Treatment (13 papers) and Biochemical and Molecular Research (5 papers). James D. Rodgers collaborates with scholars based in United States, Canada and Australia. James D. Rodgers's co-authors include Nigel J. Bunce, Wojciech Jȩdral, Ronald M. Klabe, Susan Erickson‐Viitanen, Beverly C. Cordova, Lee T. Bacheler, George L. Trainor, Jeffrey W. Corbett, Soo S. Ko and Sharon Diamond and has published in prestigious journals such as Journal of the American Chemical Society, Environmental Science & Technology and Blood.

In The Last Decade

James D. Rodgers

55 papers receiving 2.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James D. Rodgers United States 27 1.2k 576 325 270 213 62 2.7k
Dan Su China 33 891 0.7× 1.4k 2.4× 287 0.9× 60 0.2× 12 0.1× 100 4.0k
Charles W. Rees United Kingdom 34 10.7k 8.8× 2.2k 3.9× 211 0.6× 40 0.1× 26 0.1× 410 12.4k
Barry A. Murrer United Kingdom 30 1.3k 1.1× 779 1.4× 96 0.3× 5 0.0× 101 0.5× 50 3.3k
Peng Xue China 28 2.0k 1.6× 999 1.7× 43 0.1× 60 0.2× 10 0.0× 142 3.7k
Luigi G. Marzilli United States 53 3.3k 2.7× 6.1k 10.6× 180 0.6× 18 0.1× 35 0.2× 388 11.8k
Philippe Barthélémy France 42 774 0.6× 2.8k 4.9× 135 0.4× 21 0.1× 28 0.1× 302 6.4k
Wei Zhang China 51 8.5k 7.0× 2.4k 4.1× 89 0.3× 27 0.1× 67 0.3× 337 10.7k
Silvano Geremia Italy 42 2.9k 2.4× 2.0k 3.5× 26 0.1× 45 0.2× 13 0.1× 224 6.8k
Catherine L. Drennan United States 56 831 0.7× 5.6k 9.8× 142 0.4× 49 0.2× 12 0.1× 190 9.3k

Countries citing papers authored by James D. Rodgers

Since Specialization
Citations

This map shows the geographic impact of James D. Rodgers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James D. Rodgers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James D. Rodgers more than expected).

Fields of papers citing papers by James D. Rodgers

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James D. Rodgers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James D. Rodgers. The network helps show where James D. Rodgers may publish in the future.

Co-authorship network of co-authors of James D. Rodgers

This figure shows the co-authorship network connecting the top 25 collaborators of James D. Rodgers. A scholar is included among the top collaborators of James D. Rodgers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James D. Rodgers. James D. Rodgers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fridman, Jordan S., Peggy Scherle, Robert J. Collins, et al.. (2011). Preclinical Evaluation of Local JAK1 and JAK2 Inhibition in Cutaneous Inflammation. Journal of Investigative Dermatology. 131(9). 1838–1844. 88 indexed citations
2.
Shilling, Adam D., Frank M. Nedza, Thomas Emm, et al.. (2010). Metabolism, Excretion, and Pharmacokinetics of [14C]INCB018424, a Selective Janus Tyrosine Kinase 1/2 Inhibitor, in Humans. Drug Metabolism and Disposition. 38(11). 2023–2031. 86 indexed citations
3.
Liu, Phillip C.C., Eian Caulder, Jun Li, et al.. (2009). Combined Inhibition of Janus Kinase 1/2 for the Treatment of JAK2V617F-Driven Neoplasms: Selective Effects on Mutant Cells and Improvements in Measures of Disease Severity. Clinical Cancer Research. 15(22). 6891–6900. 15 indexed citations
4.
Fridman, Jordan S., Eian Caulder, Xiaoming Wen, et al.. (2009). Abstract #2848: Small molecule inhibitors of JAK1/2 improve physiological and functional measures of cancer-associated cachexia. Cancer Research. 69. 2848–2848. 1 indexed citations
5.
Jennings, Bonnie Mowinski, Cynthia C. Scalzi, James D. Rodgers, & Anne Keane. (2007). Differentiating nursing leadership and management competencies. Nursing Outlook. 55(4). 169–175.e4. 57 indexed citations
6.
Corbett, Jeffrey W. & James D. Rodgers. (2002). 3 Discovery of Second Generation Quinazolinone Non-Nucleoside Reverse Transcriptase Inhibitors of Hiv-1. Progress in medicinal chemistry. 40. 63–105. 15 indexed citations
7.
Corbett, Jeffrey W., et al.. (2001). Trifluoromethyl-containing 3-alkoxymethyl- and 3-aryloxymethyl-2-pyridinones are potent inhibitors of hIV-1 non-nucleoside reverse transcriptase. Bioorganic & Medicinal Chemistry Letters. 11(3). 309–312. 13 indexed citations
8.
Rodgers, James D. & Nigel J. Bunce. (2001). Treatment methods for the remediation of nitroaromatic explosives. Water Research. 35(9). 2101–2111. 257 indexed citations
9.
Patel, Mona, Robert J. McHugh, Beverly C. Cordova, et al.. (2001). Synthesis and evaluation of novel quinolinones as HIV-1 reverse transcriptase inhibitors. Bioorganic & Medicinal Chemistry Letters. 11(14). 1943–1945. 81 indexed citations
10.
Corbett, Jeffrey W., Soo S. Ko, James D. Rodgers, et al.. (2000). Novel 2,2-dioxide-4,4-disubstituted-1,3-H-2,1,3-benzothiadiazines as non-nucleoside reverse transcriptase inhibitors. Bioorganic & Medicinal Chemistry Letters. 10(2). 193–195. 13 indexed citations
11.
Patel, Mona, Robert J. McHugh, Beverly C. Cordova, et al.. (2000). Synthesis and evaluation of quinoxalinones as HIV-1 reverse transcriptase inhibitors. Bioorganic & Medicinal Chemistry Letters. 10(15). 1729–1731. 78 indexed citations
12.
Patel, Mona, James D. Rodgers, Robert J. McHugh, et al.. (1999). Unsymmetrical cyclic ureas as HIV-1 protease inhibitors: Novel biaryl indazoles as P2/P2′ substituents. Bioorganic & Medicinal Chemistry Letters. 9(22). 3217–3220. 53 indexed citations
13.
Rodgers, James D., Patrick Y. S. Lam, Barry L. Johnson, et al.. (1998). Design and selection of DMP 850 and DMP 851: the next generation of cyclic urea HIV protease inhibitors. Chemistry & Biology. 5(11). R312–R312. 1 indexed citations
14.
Rodgers, James D., Barry L. Johnson, Susan Erickson‐Viitanen, et al.. (1998). Potent cyclic urea HIV protease inhibitors with 3-aminoindazole P2/P2′ groups. Bioorganic & Medicinal Chemistry Letters. 8(7). 715–720. 34 indexed citations
15.
Rodgers, James D., Patrick Y. S. Lam, Haisheng Wang, et al.. (1998). Design and selection of DMP 850 and DMP 851: the next generation of cyclic urea HIV protease inhibitors. Chemistry & Biology. 5(10). 597–608. 32 indexed citations
16.
Rodgers, James D. & Robert J. Thornton. (1995). Making Operational the Concept of Maintenance Consumption. SSRN Electronic Journal. 1 indexed citations
17.
Masucci, John A., et al.. (1995). Identification of four plasma metabolites of Etoperidone in dogs. Journal of Pharmaceutical and Biomedical Analysis. 13(2). 177–184. 4 indexed citations
18.
Hochman, Harold M. & James D. Rodgers. (1975). La redistribución óptima de Pareto. Revista Hacienda Pública Española. 189–203. 1 indexed citations
19.
Hochman, Harold M. & James D. Rodgers. (1974). Redistribution and the Pareto Criterion. American Economic Review. 64(4). 752–757. 15 indexed citations
20.
Hochman, Harold M. & James D. Rodgers. (1971). Is Efficiency a Criterion for Judging Redistribution. Public finance. 26(2). 348–360. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dan Su Breakdown of academic impact, for papers by Charles W. Rees Breakdown of academic impact, for papers by Barry A. Murrer Breakdown of academic impact, for papers by Peng Xue Breakdown of academic impact, for papers by Luigi G. Marzilli Breakdown of academic impact, for papers by Philippe Barthélémy Breakdown of academic impact, for papers by Wei Zhang Breakdown of academic impact, for papers by Silvano Geremia Breakdown of academic impact, for papers by Catherine L. Drennan
Rankless by CCL
2026